Koninklijke DSM NV
AEX:DSM

Watchlist Manager
Koninklijke DSM NV Logo
Koninklijke DSM NV
AEX:DSM
Watchlist
Price: 114.05 EUR Market Closed
Market Cap: €568.6m

Relative Value

There is not enough data to reliably calculate the relative value of DSM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DSM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

DSM Competitors Multiples
Koninklijke DSM NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
Koninklijke DSM NV
AEX:DSM
568.6m EUR 0.1 0.3 1 1
US
Sherwin-Williams Co
NYSE:SHW
79.6B USD 3.4 30.9 20.1 23.7
US
Ecolab Inc
NYSE:ECL
78.1B USD 4.9 37.7 21.9 29.3
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12T JPY 4.7 24.7 12.1 16.7
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 1 10.5 5.8 7.1
CN
Wanhua Chemical Group Co Ltd
SSE:600309
280B CNY 1.6 25.2 21.6 21.6
CH
Givaudan SA
SIX:GIVN
25.7B CHF 3.4 24 16.8 21.4
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
US
PPG Industries Inc
NYSE:PPG
23.3B USD 1.4 14.4 10.1 12.6
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.1T INR 6.1 55.2 33.2 40.7
CH
Sika AG
F:SIKA
19.9B EUR 1.6 17.3 10.2 14.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NL
Koninklijke DSM NV
AEX:DSM
Average EV/EBITDA: 16.5
1
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
20.1
9%
2.2
US
Ecolab Inc
NYSE:ECL
21.9
10%
2.2
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12.1
4%
3
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
5.8
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.6
34%
0.6
CH
Givaudan SA
SIX:GIVN
16.8
6%
2.8
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
10.1
7%
1.4
IN
Asian Paints Ltd
NSE:ASIANPAINT
33.2
10%
3.3
CH
Sika AG
F:SIKA
10.2
8%
1.3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett